New Jersey, United Kingdom, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Gene Therapy Market By Vector (Viral & Non-Viral), By Delivery Mode (In Vivo & Ex Vivo), By Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026” in its research database
“According to the latest research study, the demand of global Gene Therapy Market size & share expected to reach to USD 12.9 Billion by 2026 from USD 2.7 Billion in 2020, at a compound annual growth rate (CAGR) of 22.3% during the forecast period 2021 to 2026”
What is Gene Therapy? How Big is Gene Therapy Market?
- Report Overview & Coverage
Gene therapy is a medical binomial that allows for the modification of a person’s genes in order to develop antibodies for treating or curating diseases. Gene therapies can work by employing several mechanisms such as replacing a disease-causing gene with a healthy variation of the gene or by inactivating a disease-causing gene that does not have the proper functionality. Additionally, a mechanism can include introducing a newly modified gene into the body for further eliminating a disease. The variety of gene therapies that are currently available is plasmid DNA, viral vectors, bacterial vectors, human gene-editing technology, and patient-derived cellular gene therapy products, to name a few.
Request Your Free Sample Report of Global Gene Therapy Market @ https://www.fnfresearch.com/sample/gene-therapy-market-by-type-germ-line-gene
(The free sample of this report is readily available on request)
Our Free Sample Report Includes:
- 2020 Updated Report Introduction, Overview, and In-depth industry analysis
- COVID-19 Pandemic Outbreak Impact Analysis Included
- 205+ Pages Research Report (Inclusion of Updated Research)
- Provide Chapter-wise guidance on Request
- 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)
Industry Major Market Players
- REGENBIO Inc.
- Oxford BioMedicaPlc
- Dimension Therapeutics Inc.
- Bristol-Myers Squibb Company
- SANOFI
- Applied Genetics Technologies Corporation
- Bluebird Bio Inc.
- TaxusCardium Pharmaceutical Group Inc.
- UniQure N.V.
- Shire Plc
- Cellectis S.A.
- Sangamo Therapeutics Inc.
- Gilead Lifesciences Inc.
- Shanghai Sunway Biotech Co. Ltd.
Key questions answered in this report:
- What is the projected market size & growth rate of the Gene Therapy Market?
- What are the key driving factors for the growth of the Gene Therapy Market?
- What are the top companies operative in Gene Therapy Market?
- What segments are covered in Gene Therapy Market?
- How can I get free sample reports/company profiles of the Gene Therapy Market?
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/gene-therapy-market-by-type-germ-line-gene
Market Growth Factors
The primary driving factors for the significant growth of the global gene therapy market are the increasing prevalence of cancer and other targeted disorders coupled with the rising availability of measures. Additionally, gene therapy is being granted several reimbursements from various insurance carriers which increases the revenue stream that can be generated for the market during the forecast period. Rising funding for gene therapy research coupled with the rising adoption of gene therapy therapeutics is expected to increase the footprint of the global gene therapy market during the forecast period. A dynamic competitive nature is expected to drive the market due to several initiatives that are undertaken by the key market players such as the biopharma companies.
The insurgence of the current pandemic is expected to create a positive impact on the global gene therapy market during the forecast period. The market is expected to increase in boundaries due to the added intervention of life-threatening diseases such as heart diseases, AIDS, cystic fibrosis, and age-related disorders. Rising investment in research and development activities is further expected to curate a larger market revenue for the global gene therapy market during the forecast period. However, high prices and irregular availability is expected to dim the market growth to a slower rate during the forecast period.
Global Gene Therapy Market: Report Scope
| Report Attribute | Details |
| Market Size 2020 Value | USD 2.7 Billion |
| Market Forecast for 2026 | USD 12.9 Billion |
| Expected CAGR Growth | CAGR 22.3% from 2021-2026 |
| Base Year | 2020 |
| Forecast Year | 2021-2026 |
| Top Market Players | Bluebird Bio, Inc., TaxusCardium Pharmaceutical Group, Inc., UniQure N.V., Shire Plc, Cellectis S.A. and Others |
| Segments Covered | Vectors, Delivery Mode, Indications, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Pricing Options | Request customized purchase options to meet your research needs. Explore purchase options |
Market Segmentation
The global gene therapy market can be segmented into vectors, delivery methods, indications, and regions.
The global gene therapy market can be divided into viral and non-viral vectors on the basis of vectors. The segment pertaining to non-viral vectors is expected to witness the largest market share during the advent of the forecast owing to technological advancements for physicochemical approaches in materials such as lipid, naked DNA, chromosomes, plasmid, cationic polymers, and conjugate complexes to name a few. The global gene therapy market can be fragmented into in vivo and ex vivo on the basis of delivery mode. The ex vivo segment is expected to occupy the largest market share during the advent of the forecast owing to a safer mode of operation and easy deliverables to name a few. The global gene therapy market can be broken down into neurological diseases, cancer, Duchenne muscular dystrophy, hepatological diseases, and others on the basis of indication. The segment pertaining to cancer is expected to witness the largest market share during the advent forecast period owing to the rising approval of gene therapies for the treatment of cancer coupled with the increasing prevalence of hematologic cancers to name a few.
Request Customized Copy of Report @ https://www.fnfresearch.com/customization/gene-therapy-market-by-type-germ-line-gene
(We customize your report according to your research need. Ask our sales team for report customization.)
Regional Dominance:
- North America to Shine During the Advent of the Forecast in Terms of Global Revenue Contribution
North America is expected to witness the largest market share during the advent of the forecast owing to the increasing prevalence of chronic diseases coupled with a high and overlooking healthcare expenditure to name a few. Additionally, advanced healthcare facilities coupled with a steady-state of reimbursement will increase the footprint of the gene therapy market in the region. Moreover, the rising number of key players in the region coupled with favorable regulatory approval will open new revenue opportunities for the gene therapy market in the region.
Browse in full “Gene Therapy Market By Vector (Viral & Non-Viral), By Delivery Mode (In Vivo & Ex Vivo), By Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, & Others), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 - 2026” report at https://www.fnfresearch.com/gene-therapy-market-by-type-germ-line-gene
The global gene therapy market can be segmented into:
Global Gene Therapy Market: By Vectors Segment Analysis
- Viral
- Retroviral Vector
- Gammaretroviral Vector
- Lentiviral Vector
- Adeno-Associated Vector
- Other Viral Vectors
- Retroviral Vector
- Non-Viral
- Oligonucleotides
Global Gene Therapy Market: By Delivery Mode Segment Analysis
- In Vivo
- Ex Vivo
Global Gene Therapy Market: By Indication Segment Analysis
- Neurological Diseases
- Cancer
- Duchenne Muscular Dystrophy
- Hepatological Diseases
- Others
Browse More Related Report:
Type 1 Diabetes Market: https://www.fnfresearch.com/type-1-diabetes-market-by-insulin-analog-rapid-1256
Antibody Drug Conjugates Market: https://www.fnfresearch.com/antibody-drug-conjugates-market-by-drugs-adcetris-and
Pneumonia Therapeutics Market: https://www.fnfresearch.com/pneumonia-therapeutics-market-by-product-type-drugs-branded
Plasma Therapy Market: https://www.fnfresearch.com/plasma-therapy-market-type-pure-prp-leucocyte-rich-1279
Absorbable Heart Stent Market: https://www.fnfresearch.com/absorbable-heart-stent-market
Absorbable Tissue Spacer Market: https://www.fnfresearch.com/absorbable-tissue-spacer-market
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us Twitter: https://twitter.com/fnfresearch
Contact Us:
Sanu Thomas
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 96043 17127
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com
Blog: http://fnfnewsblog.com
